LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,798 | -98.0% | 30 | -97.6% | 0.00% | -98.5% |
| Q2 2023 | $91,639 | +8208.2% | 1,271 | +8373.3% | 0.07% | +6600.0% |
| Q1 2023 | $1,103 | -98.3% | 15 | -97.8% | 0.00% | -98.4% |
| Q3 2020 | $66,000 | -77.9% | 693 | -74.0% | 0.06% | -77.7% |
| Q2 2020 | $299,000 | +116.7% | 2,670 | +143.8% | 0.27% | +97.8% |
| Q1 2019 | $138,000 | +97.1% | 1,095 | +329.4% | 0.14% | +109.1% |
| Q3 2018 | $70,000 | +29.6% | 255 | -1.9% | 0.07% | +32.0% |
| Q2 2018 | $54,000 | +25.6% | 260 | 0.0% | 0.05% | +28.2% |
| Q1 2018 | $43,000 | – | 260 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VILLERE ST DENIS J & CO LLC | 518,988 | $80,162,000 | 4.60% |
| Knott David M Jr | 75,000 | $11,585,000 | 3.93% |
| Orchard Capital Management, LLC | 68,596 | $10,595,000 | 3.11% |
| Chicago Capital, LLC | 436,456 | $67,415,000 | 2.51% |
| RICE HALL JAMES & ASSOCIATES, LLC | 347,699 | $53,706,000 | 1.91% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 85,990 | $13,282,000 | 1.46% |
| Smith, Graham & Co., Investment Advisors, LP | 87,392 | $13,499,000 | 1.34% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 44,754 | $6,913,000 | 1.12% |
| WOODSTOCK CORP | 68,666 | $10,606,000 | 1.11% |
| Stephens Investment Management Group LLC | 411,359 | $63,539,000 | 0.82% |